Suppr超能文献

探索社会决定因素与肝细胞癌:证据及影响的范围综述

Exploring social determinants and hepatocellular carcinoma: a scoping review of evidence and implications.

作者信息

Escobar Gil Tomas, Aguilar Gicel Jacklin

机构信息

Department of Internal Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.

出版信息

Proc (Bayl Univ Med Cent). 2024 Oct 17;38(1):53-60. doi: 10.1080/08998280.2024.2406030. eCollection 2025.

Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide. Social determinants of health (SDH) significantly impact HCC outcomes, yet comprehensive insights into these effects are lacking. This scoping review aimed to examine the influence of SDH on HCC outcomes.

METHODS

Following PRISMA-ScR guidelines, we searched 10 databases, including PubMed and Scopus, using terms related to HCC and SDH. We included studies published between 1994 and 2024, focusing on human participants and various study designs. A total of 20 studies were selected, including cross-sectional, cohort, and case-control studies.

RESULTS

The review identified disparities in HCC outcomes linked to socioeconomic status, health care access, and racial and ethnic differences. Patients in disadvantaged socioeconomic conditions and marginalized racial groups faced delays in treatment and worse outcomes. United States-based studies highlighted pronounced disparities compared to studies in Argentina, France, and Australia. Various SDH metrics provided inconsistent results, illustrating a need for standardized measures.

CONCLUSIONS

SDH significantly shapes HCC outcomes, revealing gaps in current research. Future studies should integrate various SDH factors using consistent metrics to improve HCC care and reduce health disparities.

摘要

背景

肝细胞癌(HCC)是全球癌症相关死亡的主要原因。健康的社会决定因素(SDH)对HCC的治疗结果有重大影响,但目前仍缺乏对这些影响的全面了解。本综述旨在探讨SDH对HCC治疗结果的影响。

方法

按照PRISMA-ScR指南,我们在10个数据库中进行检索,包括PubMed和Scopus,检索词为与HCC和SDH相关的术语。我们纳入了1994年至2024年期间发表的研究,重点关注人类参与者和各种研究设计。共筛选出20项研究,包括横断面研究、队列研究和病例对照研究。

结果

该综述发现HCC治疗结果存在差异,这些差异与社会经济地位、医疗保健可及性以及种族和民族差异有关。社会经济条件不利和处于边缘地位的种族群体的患者面临治疗延迟和更差的治疗结果。与阿根廷、法国和澳大利亚的研究相比,美国的研究突出了明显的差异。各种SDH指标的结果不一致,表明需要标准化的测量方法。

结论

SDH显著影响HCC的治疗结果,揭示了当前研究中的差距。未来的研究应使用一致的指标整合各种SDH因素,以改善HCC的治疗并减少健康差距。

相似文献

引用本文的文献

本文引用的文献

3
Inequities in primary liver cancer in Europe: The state of play.欧洲原发性肝癌的不平等现象:现状。
J Hepatol. 2024 Apr;80(4):645-660. doi: 10.1016/j.jhep.2023.12.031. Epub 2024 Jan 17.
4
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
10
Addressing racial and ethnic disparities in US liver cancer care.解决美国肝癌护理中的种族和民族差异。
Hepatol Commun. 2023 Jun 22;7(7). doi: 10.1097/HC9.0000000000000190. eCollection 2023 Jul 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验